ArticleJournal of thoracic disease2019

Respecting your elders: osimertinib demonstrates preferential activity in elderly patients with T790M positive non-small cell lung cancers.

Hiromichi Ebi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.